Global Optic Neuritis Drug Sales Market, By Therapy (Steroidal therapy, Supplementary therapy, and Immunomodulators therapy), By End-user ( Adult, Pediatric), By Distribution Channel (Hospitals, Ophthalmic Clinics, Ambulatory surgical centers), By Region (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America); Trend Analysis, Competitive Market Share & Forecast, 2020-2026

Upcoming:
January 2021
Report Code:
bwc20249
Available Format:
PDF PDF Icon
Pages:
178

global optic neuritis drug sales market

Global Optic Neuritis Drug Sales Market Size – Industry Trends & Forecast Report 2026

The Global Optic Neuritis Drug Sales Market has reached USD in 2019 and is further projected to reach USD by 2026, rising at a CAGR of throughout the forecast period. The treatment for optic neuritis, which is also named optic papillitis, is supported out by the ingesting of set corticosteroid drugs. The corticosteroid drugs are managed via both vein and oral routes of administration. The global optic neuritis drug market is predicted to see hurdles in its development during the forthcoming years, due to the lack of mindfulness among the common public concerning optic neuritis and its treatment. Also, the side-effects of oral ingesting corticosteroids for a longer duration can lead to osteoporosis, hypertension, diabetes, and cataract amid a few others. This in turn reduces the growth of the global market. However, a growing number of initiatives are being taken for spreading awareness regarding optic neuritis, along with growing investments for the research and development of optic neuritis drugs. Such measures are expected to fuel the development of the global optic neuritis drug market and offer profitable chances to the market players.




Source: BlueWeave Consulting

 

Global Optic Neuritis Drug Sales Market Overview:

 

Optic neuritis is the swelling of optic nerves that can cause optic neuropathy. It is a severe condition which if not cured well can result in numerous sclerosis. An assessment of 15-20% of the people suffering from optic neuritis is probable to end up suffering from many sclerosis. However, only 3% of the people suffering from optic neuritis are probable to lose complete visualization and go blind. As per the Optic Neuritis Foundation Inc., adults between the ages of 18-45 years are most susceptible to such a disorder. Females are said to be more prone to optic nerve soreness as compared to the male gender. As per the research studies, about 115 out of 100,00 people have optic neuritis condition in the whole world.

 

Global Optic Neuritis Drug Sales Market Forecast and Trends

 

Growth Drivers 

 

Growing awareness about early detection of optic neuritis 

Rising awareness about the early finding of optic neuritis associated with multiple sclerosis and accessibility of rational cure options are expected to drive the global optic neuritis treatment market during the forecast period. A growing number of creativities are being taken for spreading consciousness concerning optic neuritis, along with increasing investments for the research and growth of optic neuritis drugs. Such measures are anticipated to fuel the growth of the global optic neuritis drug market and offer profitable chances to the market players.

 

Increasing incidences of bacterial infection

Maximum use of prednisolone prednisone and other intravenous steroids is also expected to additional motivate the growth of the worldwide optic neuritis treatment market. The improved occurrence of bacterial contaminations is also expected to drive the global optic neuritis treatment market.


Bacterial infection trailed by multiple sclerosis is expected to be the foremost section in the global optic neuritis treatment market.

 

Restraints 

The global optic neuritis drug market is predicted to see obstacles in its development during the coming years, due to the lack of mindfulness amid the common populace pertaining to optic neuritis and its cure. In addition, the side-effects of oral ingesting corticosteroids for a longer duration can lead to osteoporosis, hypertension, diabetes, and cataract among a few others. This in turn reduces the development of the global market.

 

Impact of COVID-19 in the industry

 

While small practices have completely closed, the big ones are catering to emergencies as of now. Tele-ophthalmology is picking up and should meet the gap, though a small part. Since ophthalmologists do not see patients with active COVID-19 as of now, they are using masks and Glass shields to avoid spread from those in the incubation period. Healthcare staff checking all those who enter the hospital for fever, contact, and last travel details. Masks have been made compulsory for all. Hand sanitizers and social distancing are highlighted. There has been a big impact on practices and lockdown has totally drained cash reserves. When they start working on ophthalmology again, we are expecting a very low turnaround for patients or elective surgeries. We also expect a drop in refractive surgery and premium lens surgeries as the Indian economy will be very seriously hit by the lockdown and its concerns.

 

 

Global Optic Neuritis Drug Sales Market: By Therapy

 

In terms of the type of therapy, the market can be divided into steroidal therapy, supplementary therapy, and immunomodulators therapy. Steroidal therapy comprises cortecostreoidal drugs, which have proven efficacy for decades. Steroidal therapy is probable to hold the main market share owing to proven efficiency and easy accessibility. Supplementary therapy contains vitamin supplementation therapy with vitamin B12 and is considered to be adjacent therapy in the cure of optic neuritis. Immunomodulators therapy contains disease-modifying agents such as interferons beta1a and beta1b which are helpful in optic neuritis and many sclerosis.

 

Global Optic Neuritis Drug Sales Market: By End User

 

Based on End-User Global Optic Neuritis Drug Sales Market is divided into Adult and Pediatric. An estimate of 15-20% of the people suffering from optic neuritis is likely to end up suffering from multiple sclerosis. However, only 3% of the population suffering from optic neuritis are predictable to lose complete vision and go blind. As per the Optic Neuritis Foundation Inc., adults between the years of 18-45 are most disposed to such a disorder. Females are said to be further prone to optic nerve soreness as related to the male gender. As per the research studies, about 115 out of 100,00 people have optic neuritis illness in the whole world.

 

Global Optic Neuritis Drug Sales Market: By Distribution Channel

 

Based on the distribution channel, the global optic neuritis treatment market can be separated into hospitals, ophthalmic clinics, and ambulatory surgical centers. The hospital's section seized a major market share and is likely to endure its leadership position throughout the prediction period. Many people prefer visiting hospitals first rather than ophthalmic clinics for conduct as the cost of therapy at hospitals is lower. Ambulatory surgical centers are the less favored option for the cure of optic neuritis.

 

Global Optic Neuritis Drug Sales Market: Regional insights


North America predictable to be the major market during the estimated period. The region is anticipated to continue to lead the market during the prediction period due to the rise in the elderly population, increasing awareness among the population regarding MS and optical neuritis, and well-established health care set-up. Europe is probable to be the next foremost region during the forecast period due to the rise in volume sales of steroidal therapeutics especially corticosteroids and upcoming new launches of joint medication products. The market in the Asia Pacific is likely to grow at a high CAGR during the forecast period. The market in Latin America and Middle East & Africa is probable to expand at a sluggish CAGR during the forecast period. The increased focus by centralized governments on improving health care facilities and rising consciousness among the people are the reasons donating to the growth of the market in these regions.




Source: BlueWeave Consulting

 Recent Development

· January 05, 2021 - Ironwood Pharmaceuticals to Present at the 39th Annual J.P. Morgan Healthcare Conference.

 

· Dec. 22, 2020 - Amgen Licenses AMG 634, An Investigational Treatment For Tuberculosis And Leprosy, To Medicines Development for Global Health.

Competitive landscape

 

Key players in the Optic Neuritis Drug Sales Market include- Amgen Inc, BioAxone BioSciences Inc, Allergan Pharmaceuticals Ireland, Ironwood Pharmaceuticals Inc., Sicor Societa’ Italiana Corticosteroidi S.R.L,Quark Pharmaceuticals Inc., Regenera Pharma Ltd, NANG KUANG PHARMACEUTICAL, PFIZER SA, NEWCHEM SPA, BIOFER S.P.A, Shandong Xinhua Pharmaceutical, Shanghai General Pharmaceutical, HPGC & CR Zizhu, Regeneron Pharmaceuticals Inc. and other prominent players.           

 

Scope of the Report

Attribute

Details

Years Considered

Historical data – 2016-2019

Base Year – 2019

Forecast – 2020 – 2026

Facts Covered

Revenue in USD Billion

Market Coverage

U.S, Canada, Germany, UK, France, Italy, Spain, Brazil, Mexico, Japan, South Korea, China, India, Argentina, AUAE, South Africa, Saudi Arabia

Product/Service Segmentation

By Therapy, By End User, By Distribution Channel,By Region

Key Players

Key players for Global Optic Neuritis Drug Sales Market includes: Amgen Inc,BioAxone BioSciences Inc,Allergan Pharmaceuticals Ireland,Ironwood Pharmaceuticals Inc,Sicor Societa’ Italiana Corticosteroidi S.R.L,Quark Pharmaceuticals Inc,Regenera Pharma Ltd,NANGKUANG PHARMACEUTICAL,PFIZER SA,NEWCHEM SPA,BIOFER S.P.A,Shandong Xinhua Pharmaceutical,Shanghai General Pharmaceutical,HPGC& CR Zizhu,Regeneron Pharmaceuticals Inc.and other prominent players.  

 

By Therapy

Ø  Steroidal therapy

Ø  Supplementary therapy

Ø  Immunomodulators therapy


By End User

Ø  Adult

Ø  Pediatric


By Distribution Channel

Ø  Hospitals

Ø  Ophthalmic clinics

Ø  Ambulatory surgical centers


By Region:

Ø  Asia Pacific

Ø  North America

Ø  Europe

Ø  Middle East & Africa

Ø  Latin America

COVID-19

We've been tracking the direct impact of COVID-19 on this market, and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Contact our sales team for more details at

Contact Now

WHY CHOOSE US

  • 24/7 Research support

    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Coustom Research Service

    Ask the Analyst to customize an exclusive study to serve your research needs.

  • Quality & Accuracy

    offers best quality reports based on various authentic and accurate data findings.

  • Data Visualization

    As the business world is changing dynamically every day. We need to stay pin point in relation to data management and optimum data utilization

  • Information security

    We never share your personal and confidential information. Your personal information is safe and secure with us.